Full Papers
Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians
F. Fayad1, N. Ziade2, G.A. Karam3, W. Ghaname4, M. Khamashta5
- Department of Rheumatology, Hôtel Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon. fouadfayad@yahoo.fr
- Department of Rheumatology, Hôtel Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.
- Department of Rheumatology, Hôtel Dieu de France Hospital, and Saint Joseph University, Beirut, Lebanon.
- Department of Obstetrics and Gynaecology, Faculty of Medicine, Holy Spirit University of Kaslik, Lebanon.
- Department of Rheumatology, Dubai Hospital, UAE.
CER10895
2018 Vol.36, N°6
PI 1014, PF 1021
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 29846160 [PubMed]
Received: 16/10/2017
Accepted : 05/03/2018
In Press: 24/05/2018
Published: 06/12/2018
Abstract
OBJECTIVES:
Management of rheumatic diseases (RD) is often problematic in pregnant patients, hence the need for guideline implementation. This survey-based study aimed to assess beliefs among obstetricians and rheumatologists about managing RD in pregnant Lebanese patients.
METHODS:
Questionnaires were completed by a representative sample of rheumatologists and obstetricians practicing throughout Lebanon. Collected data included physicians’ information, opinion on pregnancy in RD patients, compatible drugs with fertility, pregnancy and breastfeeding, references used in their clinical management, referral to specialists, and knowledge about guidelines. Qualitative variables were analysed using Chi-square or Fisher’s exact tests, and quantitative variables using Wilcoxon or Student t-tests. Results were matched against a scoring system based on the EULAR/BSR guidelines. p-value <0.05 indicated statistical significance.
RESULTS:
Analysis showed high response rates of physicians, especially among rheumatologists. Overall, physicians practice was in concordance with international guidelines and only few misconceptions were reported. Systemic lupus erythematosus (SLE) was associated with risk on fertility, foetal malformation and eclampsia while anti-phospholipid (APL) syndrome was associated with miscarriage and vasculitis with eclampsia. Spondyloarthritis was considered ‘safe’ in pregnancy. Most physicians think that cyclophosphamide, leflunomide, methotrexate, mycophenolate mofetil and azathioprine compromise fertility, pregnancy, and breastfeeding.
CONCLUSIONS:
Our data showed relatively good concordance of the physicians’ beliefs with the current literature and recommendations. However, we identified misconceptions about anti-rheumatic drugs safety in pregnancy and discrepancy between rheumatologists and obstetricians practices; hence the need for promoting collaboration between both specialties and disseminating knowledge to physicians and patients in the Middle East region.
